CA2504471A1 - Formulations pharmaceutiques d'inhibiteurs du depot d'amyloide - Google Patents

Formulations pharmaceutiques d'inhibiteurs du depot d'amyloide Download PDF

Info

Publication number
CA2504471A1
CA2504471A1 CA002504471A CA2504471A CA2504471A1 CA 2504471 A1 CA2504471 A1 CA 2504471A1 CA 002504471 A CA002504471 A CA 002504471A CA 2504471 A CA2504471 A CA 2504471A CA 2504471 A1 CA2504471 A1 CA 2504471A1
Authority
CA
Canada
Prior art keywords
amyloid
formulation
therapeutic
subject
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002504471A
Other languages
English (en)
Inventor
Julie Laurin
Denis Garceau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bellus Health International Ltd
Original Assignee
Neurochem (International) Limited
Julie Laurin
Denis Garceau
Bellus Health (International) Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/871,549 external-priority patent/US20050142191A1/en
Application filed by Neurochem (International) Limited, Julie Laurin, Denis Garceau, Bellus Health (International) Limited filed Critical Neurochem (International) Limited
Publication of CA2504471A1 publication Critical patent/CA2504471A1/fr
Abandoned legal-status Critical Current

Links

CA002504471A 2004-06-18 2005-04-12 Formulations pharmaceutiques d'inhibiteurs du depot d'amyloide Abandoned CA2504471A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10/871,549 US20050142191A1 (en) 2003-06-23 2004-06-18 Pharmaceutical formulations of amyloid inhibiting compounds
US10/871,549 2004-06-18
PCT/IB2004/002381 WO2004112762A2 (fr) 2003-06-23 2004-06-21 Formulations pharmaceutiques de composes inhibiteurs de substances amyloides
EPWO2004/112762 2004-06-21
US60/640,108 2004-12-29

Publications (1)

Publication Number Publication Date
CA2504471A1 true CA2504471A1 (fr) 2005-12-18

Family

ID=35645504

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002504471A Abandoned CA2504471A1 (fr) 2004-06-18 2005-04-12 Formulations pharmaceutiques d'inhibiteurs du depot d'amyloide

Country Status (1)

Country Link
CA (1) CA2504471A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112225808A (zh) * 2012-09-12 2021-01-15 生物控股有限公司 人胰岛淀粉样多肽（hiapp）特异性抗体及其用途
EP3624788A4 (fr) * 2017-05-17 2021-03-03 Confluence Pharmaceuticals, LLC Formulations d'homotaurines et de leurs sels

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112225808A (zh) * 2012-09-12 2021-01-15 生物控股有限公司 人胰岛淀粉样多肽（hiapp）特异性抗体及其用途
EP3624788A4 (fr) * 2017-05-17 2021-03-03 Confluence Pharmaceuticals, LLC Formulations d'homotaurines et de leurs sels

Similar Documents

Publication Publication Date Title
US8835500B2 (en) Pharmaceutical formulations of amyloid inhibiting compounds
US20060079578A1 (en) Pharmaceutical formulations of amyloid inhibiting compounds
AU2002301845B2 (en) Modified release tamsulosin tablets
US5593696A (en) Stabilized composition of famotidine and sucralfate for treatment of gastrointestinal disorders
US5807579A (en) Pseudoephedrine combination pharmaceutical compositions
US20060257480A1 (en) Pharmaceutical formulations of amyloid inhibiting compounds
CA2604617A1 (fr) Composition renfermant une drogue contre la demence
AU3005800A (en) Controlled release bupropion formulation
US7253306B2 (en) Pharmaceutical drug candidates and methods for preparation thereof
EP1646659B1 (fr) Procédé de préparation de composés de l'acide 1,3-propane disulfonique
CA2504471A1 (fr) Formulations pharmaceutiques d'inhibiteurs du depot d'amyloide
US20110021813A1 (en) Pharmaceutical drug candidates and methods for preparation thereof
CA2761602C (fr) Desfesoterodine sous forme de sel d'acide tartrique
US8778395B2 (en) Diltiazem controlled release formulation and method of manufacture
AU2015268758A1 (en) Modified-release dosage forms of 5-HT2c agonists useful for weight management

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued